Research Article
Synthesis, Characterization, and Pharmacokinetic Studies of Thiazolidine-2,4-Dione Derivatives
Table 4
Pharmacokinetics of TZDs (C1–C5) derivatives calculated with SwissADME database.
| Ligands | GI absorption | Bioavailability score | BBB permeant | -gp substrate | CYP1A2 inhibitors | CYP2C19 inhibitors | CYP2C9 inhibitors | CYP2D6 inhibitors | CYP3A4 inhibitors |
| C1 | High | 0.55 | No | Yes | No | No | No | No | No | C2 | High | 0.55 | No | Yes | No | No | No | No | No | C3 | Low | 0.55 | No | Yes | No | No | Yes | No | No | C4 | High | 0.55 | No | Yes | No | No | No | No | No | C5 | High | 0.55 | No | Yes | Yes | Yes | No | No | No |
|
|